Changes of Serum Total and Free Testosterone Concentrations in Male Chronic Hemodialysis Patients with Secondary Hyperparathyroidism in Response to Cinacalcet Treatment
Background/Aims: Calcium sensing receptor (CaSR) is expressed, among others also in testis. Cinacalcet binds to the CaSR, increases sensitivity of CaSR to serum calcium and is used in the treatment of secondary hyperparathyroidism (sHPT) in chronic hemodialysis patients (HDP). In most of male HDP, s...
Saved in:
Main Authors: | Piotr Kuczera (Author), Marcin Adamczak (Author), Andrzej Wiecek (Author) |
---|---|
Format: | Book |
Published: |
Karger Publishers,
2016-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THE CARDIOVASCULAR EFFECTS OF CINACALCET IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM
by: Sungjin Chung, et al.
Published: (2012) -
Serum Anti-Müllerian Hormone Concentration in Young Women with Chronic Kidney Disease on Hemodialysis, and After Successful Kidney Transplantation
by: Ewelina Sikora-Grabka, et al.
Published: (2016) -
Pharmacogenetic analysis of cinacalcet response in secondary hyperparathyroidism patients
by: Jeong S, et al.
Published: (2016) -
Cinacalcet in treatment of the secondary hyperparathyroidism relapse in patients on dialysis
by: Olga Vetchinnikova, et al.
Published: (2012) -
Comparison between paricalcitol versus cinacalcet therapy in the management of secondary hyperparathyroidism among prevalent hemodialysis patients
by: Maha A. Behairy, et al.
Published: (2022)